Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
8 pending office actions • 6 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
BIOMERIEUX is managing 8 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 8 distinct examiners, meaning no single examiner is handling multiple cases. The portfolio spans 6 distinct art units.
DENNIS MICHAEL WHITE is the busiest examiner for the company, though he only has 1 pending office action. This distribution across various technical groups suggests that the company's biotechnology applications cover several specialized sub-fields.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 6 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOHANNSEN, DIANA B | 1 | 53.2% | +42.8% |
| WHITE, DENNIS MICHAEL | 1 | 58.0% | +48.6% |
| SCHNASE, PAUL DANIEL | 1 | 69.0% | +6.1% |
| HYUN, PAUL SANG HWA | 1 | 69.8% | +36.5% |
| GORDON, BRIAN R | 1 | 65.2% | +18.9% |
| VANNI, GEORGE STEVEN | 1 | 67.4% | +24.4% |
| THOMPSON, MILANA KAYE | 1 | 0.0% | +0.0% |
| DURYEE, ALEXANDER MARSH | 1 | 33.3% | +41.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17911074 | MOLECULAR TECHNOLOGY FOR DETECTING A GENOME SEQUENCE IN A BACTERIAL GENOME | THOMPSON, MILANA KAYE | 1d overdue |
| 18632901 | Methods For Determining Antimicrobial Drug Resistance | JOHANNSEN, DIANA B | — |
| 18700573 | METHOD FOR MANUFACTURING A BIOLOGICAL ANALYSIS CARD COMPRISING A PRETREATMENT CHAMBER PROVIDED WITH SOLID BODIES | WHITE, DENNIS MICHAEL | — |
| 18265565 | DETECTION METHOD FOR SAMPLE PRESENCE AND DEVICE ASSOCIATED | SCHNASE, PAUL DANIEL | — |
| 18000866 | DEVICE FOR HOLDING TUBES USED FOR ANALYSING SAMPLES BY MEANS OF NUCLEIC ACID AMPLIFICATION TECHNIQUES AND METHOD FOR USING SUCH A DEVICE | HYUN, PAUL SANG HWA | — |
| 17917579 | AUTOMATIC SAMPLING METHOD FOR HANDLING WHOLE BLOOD | GORDON, BRIAN R | — |
| 17910982 | MOLECULAR TECHNOLOGY FOR PREDICTING A PHENOTYPIC TRAIT OF A BACTERIUM FROM ITS GENOME | VANNI, GEORGE STEVEN | — |
| 17251297 | METHOD FOR DETECTING AND/OR IDENTIFYING AT LEAST ONE TARGET MICROORGANISM PRESENT ON A SURFACE | DURYEE, ALEXANDER MARSH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18632901 | Methods For Determining Antimicrobial Drug Resistance | JOHANNSEN, DIANA B | — |
| 18700573 | METHOD FOR MANUFACTURING A BIOLOGICAL ANALYSIS CARD COMPRISING A PRETREATMENT CHAMBER PROVIDED WITH SOLID BODIES | WHITE, DENNIS MICHAEL | — |
| 18000866 | DEVICE FOR HOLDING TUBES USED FOR ANALYSING SAMPLES BY MEANS OF NUCLEIC ACID AMPLIFICATION TECHNIQUES AND METHOD FOR USING SUCH A DEVICE | HYUN, PAUL SANG HWA | — |
| 17917579 | AUTOMATIC SAMPLING METHOD FOR HANDLING WHOLE BLOOD | GORDON, BRIAN R | — |
| 17910982 | MOLECULAR TECHNOLOGY FOR PREDICTING A PHENOTYPIC TRAIT OF A BACTERIUM FROM ITS GENOME | VANNI, GEORGE STEVEN | — |
| 17251297 | METHOD FOR DETECTING AND/OR IDENTIFYING AT LEAST ONE TARGET MICROORGANISM PRESENT ON A SURFACE | DURYEE, ALEXANDER MARSH | — |
| Art Unit | Apps |
|---|---|
| 1798 | 2 |
| 1682 | 1 |
| 1796 | 1 |
| 1686 | 1 |
| 1687 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18632901 | Methods For Determining Antimicrobial Drug Resistance | JOHANNSEN, DIANA B | 1682 | §102§112 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18700573 | METHOD FOR MANUFACTURING A BIOLOGICAL ANALYSIS CARD COMPRISING A PRETREATMENT CHAMBER PROVIDED WITH SOLID BODIES | WHITE, DENNIS MICHAEL | — | §102§103§112 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18265565 | DETECTION METHOD FOR SAMPLE PRESENCE AND DEVICE ASSOCIATED | SCHNASE, PAUL DANIEL | 1798 | §102§103§112 | Non-Final OA | — | Pending | Jun 06, 2023 |
| 18000866 | DEVICE FOR HOLDING TUBES USED FOR ANALYSING SAMPLES BY MEANS OF NUCLEIC ACID AMPLIFICATION TECHNIQUES AND METHOD FOR USING SUCH A DEVICE | HYUN, PAUL SANG HWA | 1796 | §102§103§112 | Non-Final OA | — | Pending | Dec 06, 2022 |
| 17917579 | AUTOMATIC SAMPLING METHOD FOR HANDLING WHOLE BLOOD | GORDON, BRIAN R | 1798 | §103§112 | Final Rejection | — | Pending | Oct 07, 2022 |
| 17910982 | MOLECULAR TECHNOLOGY FOR PREDICTING A PHENOTYPIC TRAIT OF A BACTERIUM FROM ITS GENOME | VANNI, GEORGE STEVEN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Sep 12, 2022 |
| 17911074 | MOLECULAR TECHNOLOGY FOR DETECTING A GENOME SEQUENCE IN A BACTERIAL GENOME | THOMPSON, MILANA KAYE | 1687 | §102§103§112DP | Non-Final OA | 1d overdue | Pending | Sep 12, 2022 |
| 17251297 | METHOD FOR DETECTING AND/OR IDENTIFYING AT LEAST ONE TARGET MICROORGANISM PRESENT ON A SURFACE | DURYEE, ALEXANDER MARSH | 1657 | §103§112 | Final Rejection | — | Pending | Dec 11, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial